Advertisement
UK Markets open in 5 hrs 8 mins
  • NIKKEI 225

    39,596.29
    -144.15 (-0.36%)
     
  • HANG SENG

    16,641.44
    -95.68 (-0.57%)
     
  • CRUDE OIL

    82.60
    -0.12 (-0.15%)
     
  • GOLD FUTURES

    2,164.20
    -0.10 (-0.00%)
     
  • DOW

    38,790.43
    +75.66 (+0.20%)
     
  • BTC-GBP

    51,822.25
    -1,352.99 (-2.54%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • Nasdaq

    16,103.45
    +130.27 (+0.82%)
     
  • ^FTAS

    4,218.89
    -3.20 (-0.08%)
     

EU Agency backs new drugs from GSK, Novartis, J&J

LONDON, Feb 21 (Reuters) - European regulators said on Friday they had recommended approval of 10 drugs, six of which were for respiratory diseases including GlaxoSmithKline (Other OTC: GLAXF - news) 's Anoro and Laventair and Novartis (Xetra: NOT.DE - news) 's Ulunar Breezhaler.

The European Medicine Agency (EMA) also gave the green light to Vokanamet, a treatment for type 2 diabetes marketed by Johnson & Johnson (NYSE: JNJ - news) .

Recommendations for marketing approval by the EMA's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.